Correlation Between AstraZeneca PLC and HUTCHMED DRC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and HUTCHMED DRC, you can compare the effects of market volatilities on AstraZeneca PLC and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and HUTCHMED DRC.

Diversification Opportunities for AstraZeneca PLC and HUTCHMED DRC

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between AstraZeneca and HUTCHMED is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and HUTCHMED DRC

Considering the 90-day investment horizon AstraZeneca PLC ADR is expected to generate 0.35 times more return on investment than HUTCHMED DRC. However, AstraZeneca PLC ADR is 2.82 times less risky than HUTCHMED DRC. It trades about 0.2 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.09 per unit of risk. If you would invest  6,573  in AstraZeneca PLC ADR on January 20, 2024 and sell it today you would earn a total of  263.00  from holding AstraZeneca PLC ADR or generate 4.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

AstraZeneca PLC ADR  vs.  HUTCHMED DRC

 Performance 
       Timeline  
AstraZeneca PLC ADR 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC ADR are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, AstraZeneca PLC is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
HUTCHMED DRC 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HUTCHMED DRC are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain fundamental indicators, HUTCHMED DRC displayed solid returns over the last few months and may actually be approaching a breakup point.

AstraZeneca PLC and HUTCHMED DRC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and HUTCHMED DRC

The main advantage of trading using opposite AstraZeneca PLC and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.
The idea behind AstraZeneca PLC ADR and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Managers
Screen money managers from public funds and ETFs managed around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance